People with HIV (PWH) are at increased risk of heart failure despite effective antiretroviral therapy. Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in aging populations; however, its prevalence and associated clinical features in contemporary PWH are not well defined.
T...
A. Reimer Jensen, L. Duus, F. Vyff et al.· European Heart Journal· 0 citations
BACKGROUND AND AIMS
People with HIV (PWH) have high risk of coronary (CAD) and peripheral (PAD) artery disease independent of traditional risk factors. Single immune-inflammatory biomarkers provide limited insight into disease risk and phenotypes, whereas integrative profiling may reveal novel mechanisms. Here we inves...
M. A. Suarez-Zdunek, A. Knudsen, Malene Hove-Skovsgaard et al.· Atherosclerosis· 0 citations
BACKGROUND
Prior to the COVID-19 pandemic, antiretroviral therapy (ART) coverage and viral suppression were improving across Europe; however, the impact of the pandemic on HIV care remains uncertain.
METHODS
In-person visits, ART coverage and viral suppression among those on ART were described in the EuroSIDA cohort...
O. Fursa, W. Bannister, G. Guaraldi et al.· HIV Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.